ERBB2 and breast cancer: This lethal breast cancer subtype is histologically classified as estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 [HER2]-negative (1, 2) and accounts for approximately 20% of all diagnosed breast cancer cases (3).